]> M-8933 C54.0 Isthmus uteri C54.1 Endometrium C54.2 Myometrium C54.3 Fundus uteri C54.8 Overlapping lesion of corpus uteri C54.9 Corpus uteri C55.9 Uterus, NOS Note 2: This schema is for adenosarcoma ONLY. When coding pay attention to the FIGO Editions and descriptions about cell and tumor types, disease extension, lymph node status and metastasis. Note 3: AJCC TNM values correspond to the stages accepted by FIGO. Note that FIGO uses a single stage value which corresponds to different groupings of T, N, and M values. &generalsize; CS Extension Note 1: Adenosarcomas of the corpus uteri were not staged in AJCC 6. Note 2: When both FIGO stage and extension detail are available, record the code with extension detail in preference to a statement of FIGO stage. Note 3: FIGO and AJCC 7 stage do not include Tis for this site and histology. Any cases with a CS Extension code of 000 will derive TX for AJCC 7 staging, though In Situ will be derived Summary Stage. Note 4: FIGO Stage IV, NOS is assigned based on tumor extension and/or metastasis. Code CS Extension based on a physician's statement of FIGO Stage IV, NOS only if it is known that the stage value is assigned because of tumor extension. Note 5: Positive cytology should be reported in CS Site-Specific Factor 2. It is not a staging element for AJCC 7 staging, but is a staging element for Summary Stage. Since "cancer cells in ascites or in peritoneal washings" was not specifically categorized in the 1977 Summary Staging Guide, is unclear to which stage previous cases may have been coded in that staging system. Note 6: According to the AJCC, extension to the bowel or bladder mucosa must be proven by biopsy in order to rule out bullous edema. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 000 TX NA IS IS 100 T1NOS NA * * 110 T1a NA * * 113 T1a NA RE RE 115 T1a NA * * 120 T1b NA * * 123 T1b NA RE RE 125 T1b NA * * 130 T1c NA * * 133 T1c NA RE RE 135 T1c NA * * 140 T1NOS NA * * 143 T1NOS NA RE RE 160 T1NOS NA * * 170 T1NOS NA * * 400 Localized, NOS T1NOS NA * * 500 T1NOS NA RE RE 510 T1a NA RE RE 520 T1a NA RE RE 550 T2a NA RE RE 600 T2a NA RE RE 605 T2a NA RE RE 610 ERROR NA RE RE 620 ERROR ERROR ERROR ERROR 640 T2b NA D RE 645 T2b NA D RE 650 T2b NA RE RE 655 T2b NA RE RE 660 T4 NA RE RE 662 T2b NA D RE 663 (655 or 662) + (640 or 645) T2b NA D RE 665 T2b NA RE RE 670 T2b NA D RE 675 FIGO Stage IIB T2b NA RE RE 680 ERROR ERROR ERROR ERROR 682 Extension beyond uterus, within pelvis, NOS T2NOS NA RE RE 683 FIGO Stage II [NOS] T2NOS NA RE RE 685 T3a NA D D 688 T3a NA D D 690 FIGO Stage IIIA T3a NA D D 692 T3b NA D D 693 T3b NA D D 694 FIGO Stage IIIB T3b NA D D 696 ERROR ERROR ERROR ERROR 698 Abdominal tissues involvement, NOS T3NOS NA D D 699 FIGO Stage III [NOS] based on extension T3NOS NA D D 700 ERROR ERROR ERROR ERROR 705 T4 NA RE RE 708 T4 NA D D 710 ERROR ERROR ERROR ERROR 715 Extension to bowel mucosa or bladder (excluding bullous edema) T4 NA D D 720 FIGO Stage IVA T4 NA D D 730 FIGO Stage IV [NOS] based on extension T4 NA D D 800 T3NOS NA D D 850 T3NOS NA D D 950 No evidence of primary tumor T0 NA U U 999 TX NA U U * For CS Extension codes 100-110, 115-120, 125-130, 135-140, and 160-400 ONLY. The SS77 and SS2000 stages are assigned based on the value of CS Extension and peritoneal cytology status coded in CS-Site Specific Factor 2 as shown in the extra table Extension Cytology Summary Stage Table. &generalcstsexteval; CS Lymph Nodes Note 1: Code only regional nodes and nodes, NOS, in this field. Distant nodes are coded in CS Mets at DX. Note 2: Regional nodes include bilateral and contralateral involvement of named nodes. Note 3: The Federation Internationale de Gynecologie et d'Obstetrique (FIGO), stages are included for coding where no more specific information is available in the record. When both FIGO stage and regional lymph node detail are available, record the code with regional lymph node detail in preference to a statement of FIGO stage. Note 4: Code CS Lymph Nodes based on a physician's statement of FIGO Stage IIIB if it is known that the stage value is assigned because of lymph node involvement, or if there is no statement that FIGO Stage IIIB is assigned based on extension or lymph node involvement. Note 5: If the clinician says "adnexa palpated" but does not mention lymph nodes, assume lymph nodes are not involved. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 000 No regional lymph node involvement N0 NA NONE NONE 100 N1 NA RN RN 200 N1 NA RN RN 500 N1 NA RN RN 800 Regional lymph node(s), NOS N1 NA RN RN 999 NX NA U U &generalregnodeseval; &generalreglnpos; &generalreglnexam; CS Mets at DX Note 1: When both Federation Internationale de Gynecologie at d-Obstetrique (FIGO) stage and metastatic detail are available, record the code with metastatic detail in preference to a statement of FIGO stage. Note 2: FIGO Stage IV, NOS is assigned based on tumor extension and/or distant metastasis. Code CS Mets at DX based on a physician's statement of FIGO Stage IV [NOS] if it is known that the stage value is assigned because of metastatic involvement, or if there is no statement that FIGO Stage IV [NOS] is assigned based on extension. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 00 No distant metastasis M0 NA NONE NONE 11 M1 NA RN D 12 M1 NA D D 40 M1 NA D D 50 M1 NA D D 55 M1 NA D D 60 M1 NA D D 70 M1 NA D D 99 M0 NA U U &generalmetseval; CS Site-Specific Factor 1 FIGO Stage Note 1: The Federation Internationale de Gynecologie et d'Obstetrique (FIGO) stage definitions do not include Stage 0 (Tis) for cervix cancer. Use code 987 for any case where CS Extension is coded 000 or 010. Note 2: Code the FIGO stage as stated in the medical record. Do not attempt to code it based on T, N, and M. Use code 999 if FIGO stage is unknown. Code Description 100 FIGO Stage l [NOS] 120 FIGO Stage lA 130 FIGO Stage 1B 140 FIGO Stage 1C 200 FIGO Stage ll [NOS] 210 FIGO Stage IIA 220 FIGO Stage IIB 300 FIGO Stage III [NOS] 310 FIGO Stage IIIA 320 FIGO Stage IIIB 330 FIGO Stage IIIC 400 402 FIGO IV [NOS] 405 FIGO Stage IVA 410 FIGO Stage IVB 888 987 988 999 FIGO stage unknown &commonssf2corpus; &commonssf3corpus; &commonssf4corpus; &commonssf5corpus; &commonssf6corpus; &commonssf7corpus; &commonssf8corpus; ¬appnewssf9; ¬appnewssf10; ¬appnewssf11; ¬appnewssf12; ¬appnewssf13; ¬appnewssf14; ¬appnewssf15; ¬appnewssf16; ¬appnewssf17; ¬appnewssf18; ¬appnewssf19; ¬appnewssf20; ¬appnewssf21; ¬appnewssf22; ¬appnewssf23; ¬appnewssf24; ¬appnewssf25; &commonhistinclusioncorpusadenosarcoma; Histology Exclusion Table AJCC 6th ed. Note: Histology codes listed in this Histology Exclusion Table for this site are codes that are not TNM staged according to the AJCC 6th Edition Cancer Staging Manual. When a case is coded in Collaborative Staging and the histology is on the exclusion list, TNM will not be calculated but SEER algorithm Summary Stage 1977 and 2000 can be assigned. For these cases, displayed results will be "T NA N NA M NA and Stage Group NA". Code Description 8240/1 Carcinoid tumor of uncertain malignant potential 8240/3 Carcinoid tumor, NOS (except of appendix M-8240/1) 8241/3 Enterochromaffin cell carcinoid 8242/1 Enterochromaffin-like cell carcinoid, NOS 8242/3 Enterochromaffin-like cell tumor, malignant 8243/3 Goblet cell carcinoid 8244/3 Composite carcinoid 8245/1 Tubular carcinoid 8245/3 Adenocarcinoid tumor 8246/3 Neuroendocrine carcinoma, NOS 8247/3 Merkel cell carcinoma (C44._) 8248/1 Apudoma 8249/3 Atypical carcinoid tumor 8680/0 Paraganglioma, benign 8680/1 Paraganglioma, NOS 8680/3 Paraganglioma, malignant 8681/1 Sympathetic paraganglioma 8682/1 Parasympathetic paraganglioma 8683/0 Gangliocytic paraganglioma (C17.0) 8690/1 Glomus jugulare tumor, NOS (C75.5) 8691/1 Aortic body tumor (C75.5) 8692/1 Carotid body tumor (C75.4) 8693/1 Extra-adrenal paraganglioma, NOS 8693/3 Extra-adrenal paraganglioma, malignant 8700/0 Pheochromocytoma, NOS (C74.1) 8700/3 Pheochromocytoma, malignant (C74.1) 8710/3 Glomangiosarcoma 8711/0 Glomus tumor, NOS 8711/3 Glomus tumor, malignant 8712/0 Glomangioma 8713/0 Glomangiomyoma 8720/0 Pigmented nevus, NOS (C44._) 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS (except juvenile melanoma M-8770/0) 8721/3 Nodular melanoma (C44._) 8722/0 Balloon cell nevus (C44._) 8722/3 Balloon cell melanoma (C44._) 8723/0 Halo nevus (C44._) 8723/3 Malignant melanoma, regressing (C44._) 8725/0 Neuronevus (C44._) 8726/0 Magnocellular nevus (C69.4) 8727/0 Dysplastic nevus (C44._) 8728/0 Diffuse melanocytosis (C70.9) 8728/1 Meningeal melanocytoma (C70.9) 8728/3 Meningeal melanomatosis (C70.9) 8730/0 Nonpigmented nevus (C44._) 8730/3 Amelanotic melanoma (C44._) 8740/0 Junctional nevus, NOS (C44._) 8740/3 Malignant melanoma in junctional nevus (C44._) 8741/2 Precancerous melanosis, NOS (C44._) 8741/3 Malignant melanoma in precancerous melanosis (C44._) 8742/2 Lentigo maligna (C44._) 8742/3 Lentigo maligna melanoma (C44._) 8743/3 Superficial spreading melanoma (C44._) 8744/3 Acral lentiginous melanoma, malignant (C44._) 8745/3 Desmoplastic melanoma, malignant (C44._) 8746/3 Mucosal lentiginous melanoma 8750/0 Intradermal nevus (C44._) 8760/0 Compound nevus (C44._) 8761/0 Small congenital nevus (C44._) 8761/1 Giant pigmented nevus, NOS (C44._) 8761/3 Malignant melanoma in giant pigmented nevus (C44._) 8762/1 Proliferative dermal lesion in congenital nevus (C44._) 8770/0 Epithelioid and spindle cell nevus (C44._) 8770/3 Mixed epithelioid and spindle cell melanoma 8771/0 Epithelioid cell nevus (C44._) 8771/3 Epithelioid cell melanoma 8772/0 Spindle cell nevus, NOS (C44._) 8772/3 Spindle cell melanoma, NOS 8773/3 Spindle cell melanoma, type A (C69._) 8774/3 Spindle cell melanoma, type B (C69._) 8780/0 Blue nevus, NOS (C44._) 8780/3 Blue nevus, malignant (C44._) 8790/0 Cellular blue nevus (C44._) 8800/0 Soft tissue tumor, benign 8800/3 Sarcoma, NOS 8800/9 Sarcomatosis, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma (except of bone M-9250/3) 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor 8810/0 Fibroma, NOS 8810/1 Cellular fibroma (C56.9) 8810/3 Fibrosarcoma, NOS 8811/0 Fibromyxoma 8811/3 Fibromyxosarcoma 8812/0 Periosteal fibroma (C40._, C41._) 8812/3 Periosteal fibrosarcoma (C40._, C41._) 8813/0 Fascial fibroma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/0 Solitary fibrous tumor 8815/3 Solitary fibrous tumor, malignant 8820/0 Elastofibroma 8821/1 Aggressive fibromatosis 8822/1 Abdominal fibromatosis 8823/0 Desmoplastic fibroma 8824/0 Myofibroma 8824/1 Myofibromatosis 8825/0 Myofibroblastoma 8825/1 Myofibroblastic tumor, NOS 8826/0 Angiomyofibroblastoma 8827/1 Myofibroblastic tumor, peribronchial (C34._) 8830/0 Benign fibrous histiocytoma 8830/1 Atypical fibrous histiocytoma 8830/3 Malignant fibrous histiocytoma 8831/0 Histiocytoma, NOS 8832/0 Dermatofibroma, NOS (C44._) 8832/3 Dermatofibrosarcoma, NOS (C44._) 8833/3 Pigmented dermatofibrosarcoma protuberans (C44._) 8834/1 Giant cell fibroblastoma 8835/1 Plexiform fibrohistiocytic tumor 8836/1 Angiomatoid fibrous histiocytoma 8840/0 Myxoma, NOS 8840/3 Myxosarcoma 8841/1 Angiomyxoma 8842/0 Ossifying fibromyxoid tumor 8850/0 Lipoma, NOS 8850/1 Atypical lipoma 8850/3 Liposarcoma, NOS 8851/0 Fibrolipoma 8851/3 Liposarcoma, well differentiated 8852/0 Fibromyxolipoma 8852/3 Myxoid liposarcoma 8853/3 Round cell liposarcoma 8854/0 Pleomorphic lipoma 8854/3 Pleomorphic liposarcoma 8855/3 Mixed liposarcoma 8856/0 Intramuscular lipoma 8857/0 Spindle cell lipoma 8857/3 Fibroblastic liposarcoma 8858/3 Dedifferentiated liposarcoma 8860/0 Angiomyolipoma 8861/0 Angiolipoma, NOS 8862/0 Chondroid lipoma 8870/0 Myelolipoma 8880/0 Hibernoma 8881/0 Lipoblastomatosis 8890/0 Leiomyoma, NOS 8890/1 Leiomyomatosis, NOS 8890/3 Leiomyosarcoma, NOS 8891/0 Epithelioid leiomyoma 8891/3 Epithelioid leiomyosarcoma 8892/0 Cellular leiomyoma 8893/0 Bizarre leiomyoma 8894/0 Angiomyoma 8894/3 Angiomyosarcoma 8895/0 Myoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma 8897/1 Smooth muscle tumor of uncertain malignant potential 8898/1 Metastasizing leiomyoma 8900/0 Rhabdomyoma, NOS 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma 8903/0 Fetal rhabdomyoma 8904/0 Adult rhabdomyoma 8905/0 Genital rhabdomyoma (C51._, C52.9) 8910/3 Embryonal rhabdomyosarcoma, NOS 8912/3 Spindle cell rhabdomyosarcoma 8920/3 Alveolar rhabdomyosarcoma 8921/3 Rhabdomyosarcoma with ganglionic differentiation 8930/0 Endometrial stromal nodule (C54.1) 8930/3 Endometrial stromal sarcoma, NOS (C54.1) 8931/3 Endometrial stromal sarcoma, low grade (C54.1) 8932/0 Adenomyoma 8933/3 Adenosarcoma 8934/3 Carcinofibroma 8935/0 Stromal tumor, benign 8935/1 Stromal tumor, NOS 8935/3 Stromal sarcoma, NOS 8936/0 Gastrointestinal stromal tumor, benign 8936/1 Gastrointestinal stromal tumor, NOS 8936/3 Gastrointestinal stromal sarcoma 8959/0 Benign cystic nephroma (C64.9) 8959/1 Cystic partially differentiated nephroblastoma (C64.9) 8959/3 Malignant cystic nephroma (C64.9) 8960/1 Mesoblastic nephroma 8960/3 Nephroblastoma, NOS (C64.9) 8963/3 Malignant rhabdoid tumor 8964/3 Clear cell sarcoma of kidney (C64.9) 8965/0 Nephrogenic adenofibroma (C64.9) 8966/0 Renomedullary interstitial cell tumor (C64.9) 8967/0 Ossifying renal tumor (C64.9) 8970/3 Hepatoblastoma (C22.0) 8971/3 Pancreatoblastoma (C25._) 8972/3 Pulmonary blastoma (C34._) 8973/3 Pleuropulmonary blastoma 8974/1 Sialoblastoma 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal 8982/0 Myoepithelioma 8982/3 Malignant myoepithelioma 8983/0 Adenomyoepithelioma (C50._) 8990/0 Mesenchymoma, benign 8990/1 Mesenchymoma, NOS 8990/3 Mesenchymoma, malignant 8991/3 Embryonal sarcoma 9000/0 Brenner tumor, NOS (C56.9) 9000/1 Brenner tumor, borderline malignancy (C56.9) 9000/3 Brenner tumor, malignant (C56.9) 9010/0 Fibroadenoma, NOS (C50._) 9011/0 Intracanalicular fibroadenoma (C50._) 9012/0 Pericanalicular fibroadenoma (C50._) 9013/0 Adenofibroma, NOS 9014/0 Serous adenofibroma, NOS 9014/1 Serous adenofibroma of borderline malignancy 9014/3 Serous adenocarcinofibroma 9015/0 Mucinous adenofibroma, NOS 9015/1 Mucinous adenofibroma of borderline malignancy 9015/3 Mucinous adenocarcinofibroma 9016/0 Giant fibroadenoma (C50._) 9020/0 Phyllodes tumor, benign (C50._) 9020/1 Phyllodes tumor, borderline (C50._) 9020/3 Phyllodes tumor, malignant (C50._) 9030/0 Juvenile fibroadenoma (C50._) 9040/0 Synovioma, benign 9040/3 Synovial sarcoma, NOS 9041/3 Synovial sarcoma, spindle cell 9042/3 Synovial sarcoma, epithelioid cell 9043/3 Synovial sarcoma, biphasic 9044/3 Clear cell sarcoma, NOS (except of kidney M-8964/3) 9050/0 Mesothelioma, benign 9050/3 Mesothelioma, malignant 9051/0 Fibrous mesothelioma, benign 9051/3 Fibrous mesothelioma, malignant 9052/0 Epithelioid mesothelioma, benign 9052/3 Epithelioid mesothelioma, malignant 9053/3 Mesothelioma, biphasic, malignant 9054/0 Adenomatoid tumor, NOS 9055/0 Multicystic mesothelioma, benign 9055/1 Cystic mesothelioma, NOS (C48._) 9060/3 Dysgerminoma 9061/3 Seminoma, NOS (C62._) 9062/3 Seminoma, anaplastic (C62._) 9063/3 Spermatocytic seminoma (C62._) 9064/2 Intratubular malignant germ cells (C62._) 9064/3 Germinoma 9065/3 Germ cell tumor, nonseminomatous (C62._) 9070/3 Embryonal carcinoma, NOS 9071/3 Yolk sac tumor 9072/3 Polyembryoma 9073/1 Gonadoblastoma 9080/0 Teratoma, benign 9080/1 Teratoma, NOS 9080/3 Teratoma, malignant, NOS 9081/3 Teratocarcinoma 9082/3 Malignant teratoma, undifferentiated 9083/3 Malignant teratoma, intermediate 9084/0 Dermoid cyst, NOS 9084/3 Teratoma with malignant transformation 9085/3 Mixed germ cell tumor 9090/0 Struma ovarii, NOS (C56.9) 9090/3 Struma ovarii, malignant (C56.9) 9091/1 Strumal carcinoid (C56.9) 9100/0 Hydatidiform mole, NOS (C58.9) 9100/1 Invasive hydatidiform mole (C58.9) 9100/3 Choriocarcinoma, NOS 9101/3 Choriocarcinoma combined with other germ cell elements 9102/3 Malignant teratoma, trophoblastic 9103/0 Partial hydatidiform mole (C58.9) 9104/1 Placental site trophoblastic tumor (C58.9) 9105/3 Trophoblastic tumor, epithelioid 9110/0 Mesonephroma, benign 9110/1 Mesonephric tumor, NOS 9110/3 Mesonephroma, malignant 9120/0 Hemangioma, NOS 9120/3 Hemangiosarcoma 9121/0 Cavernous hemangioma 9122/0 Venous hemangioma 9123/0 Racemose hemangioma 9124/3 Kupffer cell sarcoma (C22.0) 9125/0 Epithelioid hemangioma 9130/0 Hemangioendothelioma, benign 9130/1 Hemangioendothelioma, NOS 9130/3 Hemangioendothelioma, malignant 9131/0 Capillary hemangioma 9132/0 Intramuscular hemangioma 9133/1 Epithelioid hemangioendothelioma, NOS 9133/3 Epithelioid hemangioendothelioma, malignant 9135/1 Endovascular papillary angioendothelioma 9136/1 Spindle cell hemangioendothelioma 9140/3 Kaposi sarcoma 9141/0 Angiokeratoma 9142/0 Verrucous keratotic hemangioma 9150/0 Hemangiopericytoma, benign 9150/1 Hemangiopericytoma, NOS 9150/3 Hemangiopericytoma, malignant 9160/0 Angiofibroma, NOS 9161/0 Acquired tufted hemangioma 9161/1 Hemangioblastoma 9170/0 Lymphangioma, NOS 9170/3 Lymphangiosarcoma 9171/0 Capillary lymphangioma 9172/0 Cavernous lymphangioma 9173/0 Cystic lymphangioma 9174/0 Lymphangiomyoma 9174/1 Lymphangiomyomatosis 9175/0 Hemolymphangioma 9180/0 Osteoma, NOS (C40._, C41._) 9180/3 Osteosarcoma, NOS (C40._, C41._) 9181/3 Chondroblastic osteosarcoma (C40._, C41._) 9182/3 Fibroblastic osteosarcoma (C40._, C41._) 9183/3 Telangiectatic osteosarcoma (C40._, C41._) 9184/3 Osteosarcoma in Paget disease of bone (C40._, C41._) 9185/3 Small cell osteosarcoma (C40._, C41._) 9186/3 Central osteosarcoma (C40._, C41._) 9187/3 Intraosseous well differentiated osteosarcoma (C40._, C41._) 9191/0 Osteoid osteoma, NOS (C40._, C41._) 9192/3 Parosteal osteosarcoma (C40._, C41._) 9193/3 Periosteal osteosarcoma (C40._, C41._) 9194/3 High grade surface osteosarcoma (C40._, C41._) 9195/3 Intracortical osteosarcoma (C40._, C41._) 9200/0 Osteoblastoma, NOS (C40._, C41._) 9200/1 Aggressive osteoblastoma (C40._, C41._) 9210/0 Osteochondroma (C40._, C41._) 9210/1 Osteochondromatosis, NOS (C40._, C41._) 9220/0 Chondroma, NOS (C40._, C41._) 9220/1 Chondromatosis, NOS 9220/3 Chondrosarcoma, NOS (C40._, C41._) 9221/0 Juxtacortical chondroma (C40._, C41._) 9221/3 Juxtacortical chondrosarcoma (C40._, C41._) 9230/0 Chondroblastoma, NOS (C40._, C41._) 9230/3 Chondroblastoma, malignant (C40._, C41._) 9231/3 Myxoid chondrosarcoma 9240/3 Mesenchymal chondrosarcoma 9241/0 Chondromyxoid fibroma (C40._, C41._) 9242/3 Clear cell chondrosarcoma (C40._, C41._) 9243/3 Dedifferentiated chondrosarcoma (C40._, C41._) 9250/1 Giant cell tumor of bone, NOS (C40._, C41._) 9250/3 Giant cell tumor of bone, malignant (C40._, C41._) 9251/1 Giant cell tumor of soft parts, NOS 9251/3 Malignant giant cell tumor of soft parts 9252/0 Tenosynovial giant cell tumor (C49._) 9252/3 Malignant tenosynovial giant cell tumor (C49._) 9260/3 Ewing sarcoma 9261/3 Adamantinoma of long bones (C40._) 9262/0 Ossifying fibroma 9270/0 Odontogenic tumor, benign 9270/1 Odontogenic tumor, NOS 9270/3 Odontogenic tumor, malignant 9271/0 Ameloblastic fibrodentinoma 9272/0 Cementoma, NOS 9273/0 Cementoblastoma, benign 9274/0 Cementifying fibroma 9275/0 Gigantiform cementoma 9280/0 Odontoma, NOS 9281/0 Compound odontoma 9282/0 Complex odontoma 9290/0 Ameloblastic fibro-odontoma 9290/3 Ameloblastic odontosarcoma 9300/0 Adenomatoid odontogenic tumor 9301/0 Calcifying odontogenic cyst 9302/0 Odontogenic ghost cell tumor 9310/0 Ameloblastoma, NOS 9310/3 Ameloblastoma, malignant 9311/0 Odontoameloblastoma 9312/0 Squamous odontogenic tumor 9320/0 Odontogenic myxoma 9321/0 Central odontogenic fibroma 9322/0 Peripheral odontogenic fibroma 9330/0 Ameloblastic fibroma 9330/3 Ameloblastic fibrosarcoma 9340/0 Calcifying epithelial odontogenic tumor 9341/1 Clear cell odontogenic tumor 9342/3 Odontogenic carcinosarcoma 9350/1 Craniopharyngioma (C75.2) 9351/1 Craniopharyngioma, adamantinomatous (C75.2) 9352/1 Craniopharyngioma, papillary (C75.2) 9360/1 Pinealoma (C75.3) 9361/1 Pineocytoma (C75.3) 9362/3 Pineoblastoma (C75.3) 9363/0 Melanotic neuroectodermal tumor 9364/3 Peripheral neuroectodermal tumor 9365/3 Askin tumor 9370/3 Chordoma, NOS 9371/3 Chondroid chordoma 9372/3 Dedifferentiated chordoma 9373/0 Parachordoma 9380/3 Glioma, malignant (C71._) 9381/3 Gliomatosis cerebri (C71._) 9382/3 Mixed glioma (C71._) 9383/1 Subependymoma (C71._) 9384/1 Subependymal giant cell astrocytoma (C71._) 9390/0 Choroid plexus papilloma, NOS (C71.5) 9390/1 Atypical choroid plexus papilloma (C71.5) 9390/3 Choroid plexus carcinoma (C71.5) 9391/3 Ependymoma, NOS (C71._) 9392/3 Ependymoma, anaplastic (C71._) 9393/3 Papillary ependymoma (C71._) 9394/1 Myxopapillary ependymoma (C72.0) 9400/3 Astrocytoma, NOS (C71._) 9401/3 Astrocytoma, anaplastic (C71._) 9410/3 Protoplasmic astrocytoma (C71._) 9411/3 Gemistocytic astrocytoma (C71._) 9412/1 Desmoplastic infantile astrocytoma (C71._) 9413/0 Dysembryoplastic neuroepithelial tumor 9420/3 Fibrillary astrocytoma (C71._) 9421/1 Pilocytic astrocytoma (C71._) 9423/3 Polar spongioblastoma (C71._) 9424/3 Pleomorphic xanthoastrocytoma (C71._) 9430/3 Astroblastoma (C71._) 9440/3 Glioblastoma, NOS (C71._) 9441/3 Giant cell glioblastoma (C71._) 9442/1 Gliofibroma (C71._) 9442/3 Gliosarcoma (C71._) 9444/1 Chordoid glioma (C71._) 9450/3 Oligodendroglioma, NOS (C71._) 9451/3 Oligodendroglioma, anaplastic (C71._) 9460/3 Oligodendroblastoma (C71._) [obs] 9470/3 Medulloblastoma, NOS (C71.6) 9471/3 Desmoplastic nodular medulloblastoma (C71.6) 9472/3 Medullomyoblastoma (C71.6) 9473/3 Primitive neuroectodermal tumor, NOS 9474/3 Large cell medulloblastoma (C71.6) 9480/3 Cerebellar sarcoma, NOS (C71.6) [obs] 9490/0 Ganglioneuroma 9490/3 Ganglioneuroblastoma 9491/0 Ganglioneuromatosis 9492/0 Gangliocytoma 9493/0 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6) 9500/3 Neuroblastoma, NOS 9501/0 Medulloepithelioma, benign (C69.4) 9501/3 Medulloepithelioma, NOS 9502/0 Teratoid medulloepithelioma, benign (C69.4) 9502/3 Teratoid medulloepithelioma 9503/3 Neuroepithelioma, NOS 9504/3 Spongioneuroblastoma 9505/1 Ganglioglioma, NOS 9505/3 Ganglioglioma, anaplastic 9506/1 Central neurocytoma 9507/0 Pacinian tumor 9508/3 Atypical teratoid/rhabdoid tumor (C71._) 9510/0 Retinocytoma (C69.2) 9510/3 Retinoblastoma, NOS (C69.2) 9511/3 Retinoblastoma, differentiated (C69.2) 9512/3 Retinoblastoma, undifferentiated (C69.2) 9513/3 Retinoblastoma, diffuse (C69.2) 9514/1 Retinoblastoma, spontaneously regressed (C69.2) 9520/3 Olfactory neurogenic tumor 9521/3 Olfactory neurocytoma (C30.0) 9522/3 Olfactory neuroblastoma (C30.0) 9523/3 Olfactory neuroepithelioma (C30.0) 9530/0 Meningioma, NOS 9530/1 Meningiomatosis, NOS 9530/3 Meningioma, malignant 9531/0 Meningothelial meningioma 9532/0 Fibrous meningioma 9533/0 Psammomatous meningioma 9534/0 Angiomatous meningioma 9535/0 Hemangioblastic meningioma [obs] 9537/0 Transitional meningioma 9538/1 Clear cell meningioma 9538/3 Papillary meningioma 9539/1 Atypical meningioma 9539/3 Meningeal sarcomatosis 9540/0 Neurofibroma, NOS 9540/1 Neurofibromatosis, NOS 9540/3 Malignant peripheral nerve sheath tumor 9541/0 Melanotic neurofibroma 9550/0 Plexiform neurofibroma 9560/0 Neurilemoma, NOS 9560/1 Neurinomatosis 9560/3 Neurilemoma, malignant [obs] 9561/3 Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation 9562/0 Neurothekeoma 9570/0 Neuroma, NOS 9571/0 Perineurioma, NOS 9571/3 Perineurioma, malignant 9580/0 Granular cell tumor, NOS 9580/3 Granular cell tumor, malignant 9581/3 Alveolar soft part sarcoma 9582/0 Granular cell tumor of the sellar region (C75.1) 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin, NOS 9596/3 Composite Hodgkin and non-Hodgkin lymphoma 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocyte depletion, NOS 9654/3 Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyte depletion, reticular 9659/3 Hodgkin lymphoma, nodular lymphocyte predominance 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nodular sclerosis, cellular phase 9665/3 Hodgkin lymphoma, nodular sclerosis, grade 1 9667/3 Hodgkin lymphoma, nodular sclerosis, grade 2 9673/3 Mantle cell lymphoma 9675/3 Malignant lymphoma, mixed small and large cell, diffuse [obs] (see also M-9690/3) 9678/3 Primary effusion lymphoma 9679/3 Mediastinal large B-cell lymphoma (C38.3) 9680/3 Malignant lymphoma, large B-cell, diffuse, NOS 9684/3 Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS (see also M-9826/3) 9689/3 Splenic marginal zone B-cell lymphoma (C42.2) 9690/3 Follicular lymphoma, NOS (see also M-9675/3) 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS 9700/3 Mycosis fungoides (C44._) 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma 9708/3 Subcutaneous panniculitis-like T-cell lymphoma 9709/3 Cutaneous T-cell lymphoma, NOS (C44._) 9714/3 Anaplastic large cell lymphoma, T cell and Null cell type 9716/3 Hepatosplenic ?? (gamma-delta) cell lymphoma 9717/3 Intestinal T-cell lymphoma 9718/3 Primary cutaneous CD30+ T-cell lymphoproliferative disorder (C44._) 9719/3 NK/T-cell lymphoma, nasal and nasal-type 9727/3 Precursor cell lymphoblastic lymphoma, NOS (see also M-9835/3) 9728/3 Precursor B-cell lymphoblastic lymphoma (see also M-9836/3) 9729/3 Precursor T-cell lymphoblastic lymphoma (see also M-9837/3) 9731/3 Plasmacytoma, NOS 9732/3 Multiple myeloma (C42.1) 9733/3 Plasma cell leukemia (C42.1) 9734/3 Plasmacytoma, extramedullary (not occurring in bone) 9740/1 Mastocytoma, NOS 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9742/3 Mast cell leukemia (C42.1) 9750/3 Malignant histiocytosis 9751/1 Langerhans cell histiocytosis, NOS 9752/1 Langerhans cell histiocytosis, unifocal 9753/1 Langerhans cell histiocytosis, multifocal 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9760/3 Immunoproliferative disease, NOS 9761/3 Waldenstrom macroglobulinemia (C42.0) (see also M-9671/3) 9762/3 Heavy chain disease, NOS 9764/3 Immunoproliferative small intestinal disease (C17._) 9765/1 Monoclonal gammopathy of undetermined significance 9766/1 Angiocentric immunoproliferative lesion 9767/1 Angioimmunoblastic lymphadenopathy 9768/1 T-gamma lymphoproliferative disease 9769/1 Immunoglobulin deposition disease 9800/3 Leukemia, NOS 9801/3 Acute leukemia, NOS 9805/3 Acute biphenotypic leukemia 9820/3 Lymphoid leukemia, NOS 9823/3 B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (see also M-9670/3) 9826/3 Burkitt cell leukemia (see also M-9687/3) 9827/3 Adult T-cell leukemia/lymphoma (HTLV-1 positive) Includes all variants 9831/1 T-cell large granular lymphocytic leukemia 9832/3 Prolymphocytic leukemia, NOS 9833/3 Prolymphocytic leukemia, B-cell type 9834/3 Prolymphocytic leukemia, T-cell type 9835/3 Precursor cell lymphoblastic leukemia, NOS (see also M-9727/3) 9836/3 Precursor B-cell lymphoblastic leukemia (see also M-9728/3) 9837/3 Precursor T-cell lymphoblastic leukemia (see also M-9729/3) 9840/3 Acute myeloid leukemia, M6 type 9860/3 Myeloid leukemia, NOS 9861/3 Acute myeloid leukemia, NOS (FAB or WHO type not specified) (see also M-9930/3) 9863/3 Chronic myeloid leukemia, NOS 9866/3 Acute promyelocytic leukemia, t(15;17)(q22;q11-12) 9867/3 Acute myelomonocytic leukemia 9870/3 Acute basophilic leukemia 9871/3 Acute myeloid leukemia with abnormal marrow eosinophils Includes all variants 9872/3 Acute myeloid leukemia, minimal differentiation 9873/3 Acute myeloid leukemia without maturation 9874/3 Acute myeloid leukemia with maturation 9875/3 Chronic myelogenous leukemia, BCR/ABL positive 9876/3 Atypical chronic myeloid leukemia, BCR/ABL negative 9891/3 Acute monocytic leukemia 9895/3 Acute myeloid leukemia with multilineage dysplasia 9896/3 Acute myeloid leukemia, t(8;21)(q22;q22) 9897/3 Acute myeloid leukemia, 11q23 abnormalities 9910/3 Acute megakaryoblastic leukemia 9920/3 Therapy-related acute myeloid leukemia, NOS 9930/3 Myeloid sarcoma (see also M-9861/3) 9931/3 Acute panmyelosis with myelofibrosis (C42.1) 9940/3 Hairy cell leukemia (C42.1) 9945/3 Chronic myelomonocytic leukemia, NOS 9946/3 Juvenile myelomonocytic leukemia 9948/3 Aggressive NK-cell leukemia 9950/3 Polycythemia vera 9960/3 Chronic myeloproliferative disease, NOS 9961/3 Myelosclerosis with myeloid metaplasia 9962/3 Essential thrombocythemia 9963/3 Chronic neutrophilic leukemia 9964/3 Hypereosinophilic syndrome 9970/1 Lymphoproliferative disorder, NOS 9975/1 Myeloproliferative disease, NOS 9980/3 Refractory anemia 9982/3 Refractory anemia with sideroblasts 9983/3 Refractory anemia with excess blasts 9984/3 Refractory anemia with excess blasts in transformation [obs] 9985/3 Refractory cytopenia with multilineage dysplasia 9986/3 Myelodysplastic syndrome with 5q deletion (5q-) syndrome 9987/3 Therapy-related myelodysplastic syndrome, NOS 9989/3 Myelodysplastic syndrome, NOS AJCC TNM 7 Stage T N M Stage T0 N0 M0 ERROR T0 N1 M0 IIIC T0 NX M0 UNK T1a N0 M0 IA T1a N1 M0 IIIC T1a NX M0 UNK T1b N0 M0 IB T1b N1 M0 IIIC T1b NX M0 UNK T1c N0 M0 IC T1c N1 M0 IIIC T1c NX M0 UNK T1NOS N0 M0 INOS T1NOS N1 M0 IIIC T1NOS NX M0 UNK T2a N0 M0 IIA T2a N1 M0 IIIC T2a NX M0 UNK T2b N0 M0 IIB T2b N1 M0 IIIC T2b NX M0 UNK T2NOS N0 M0 IINOS T2NOS N1 M0 IIIC T2NOS NX M0 UNK T3a N0 M0 IIIA T3a N1 M0 IIIC T3a NX M0 IIINOS T3b N0 M0 IIIB T3b N1 M0 IIIC T3b NX M0 IIINOS T3NOS N0 M0 IIINOS T3NOS N1 M0 IIIC T3NOS NX M0 IIINOS T4 N0 M0 IVA T4 N1 M0 IVA T4 NX M0 IVA TX N0 M0 UNK TX N1 M0 UNK TX NX M0 UNK T0 N0 M1 IVB T0 N1 M1 IVB T0 NX M1 IVB T1a N0 M1 IVB T1a N1 M1 IVB T1a NX M1 IVB T1b N0 M1 IVB T1b N1 M1 IVB T1b NX M1 IVB T1c N0 M1 IVB T1c N1 M1 IVB T1c NX M1 IVB T1NOS N0 M1 IVB T1NOS N1 M1 IVB T1NOS NX M1 IVB T2a N0 M1 IVB T2a N1 M1 IVB T2a NX M1 IVB T2b N0 M1 IVB T2b N1 M1 IVB T2b NX M1 IVB T2NOS N0 M1 IVB T2NOS N1 M1 IVB T2NOS NX M1 IVB T3a N0 M1 IVB T3a N1 M1 IVB T3a NX M1 IVB T3b N0 M1 IVB T3b N1 M1 IVB T3b NX M1 IVB T3NOS N0 M1 IVB T3NOS N1 M1 IVB T3NOS NX M1 IVB T4 N0 M1 IVB T4 N1 M1 IVB T4 NX M1 IVB TX N0 M1 IVB TX N1 M1 IVB TX NX M1 IVB ¬appcsstage; &commonsummarystage; Extension Cytology Summary Stage Table Note: For CS Extension codes 100-110, 115-120, 125-130, 135-140, and 160-400 ONLY. The SS77 and SS2000 stages are assigned based on the value of CS Extension and peritoneal cytology status coded in CS Site Specific Factor 2 (SSF2) as shown in this table. CS SSF2 SS77/SS2000 Category 000 L 010 RE 020 L 888 ERROR 988-999 L